Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Enzymes Market, by Source
1.4.2 North America Enzymes Market, by Type
1.4.3 North America Enzymes Market, by Reaction Type
1.4.4 North America Enzymes Market, by Application
1.4.5 North America Enzymes Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Dec – 2021, Feb) Leading Players
Chapter 4. North America Enzymes Market by Source
4.1 North America Animals Market by Country
4.2 North America Plants Market by Country
4.3 North America Microorganisms Market by Country
Chapter 5. North America Enzymes Market by Type
5.1 North America Protease Market by Country
5.2 North America Carbohydrase Market by Country
5.3 North America Lipase Market by Country
5.4 North America Polymerase and Nuclease Market by Country
5.5 North America Other Types Market by Country
Chapter 6. North America Enzymes Market by Reaction Type
6.1 North America Transferase Market by Country
6.2 North America Lyase Market by Country
6.3 North America Hydrolase Market by Region
6.4 North America Oxidoreductase Market by Region
6.5 North America Other Reaction Types Market by Region
Chapter 7. North America Enzymes Market by Application
7.1 North America Household Care Market by Country
7.2 North America Bioenergy Market by Country
7.3 North America Pharmaceutical and Biotechnology Market by Country
7.4 North America Food & Beverages Market by Country
7.5 North America Feed Market by Country
7.6 North America Others Market by Country
Chapter 8. North America Enzymes Market by Region
8.1 US Enzymes Market
8.1.1 US Enzymes Market by Source
8.1.2 US Enzymes Market by Type
8.1.3 US Enzymes Market by Reaction Type
8.1.4 US Enzymes Market by Application
8.2 Canada Enzymes Market
8.2.1 Canada Enzymes Market by Source
8.2.2 Canada Enzymes Market by Type
8.2.3 Canada Enzymes Market by Reaction Type
8.2.4 Canada Enzymes Market by Application
8.3 Mexico Enzymes Market
8.3.1 Mexico Enzymes Market by Source
8.3.2 Mexico Enzymes Market by Type
8.3.3 Mexico Enzymes Market by Reaction Type
8.3.4 Mexico Enzymes Market by Application
8.4 Rest of North America Enzymes Market
8.4.1 Rest of North America Enzymes Market by Source
8.4.2 Rest of North America Enzymes Market by Type
8.4.3 Rest of North America Enzymes Market by Reaction Type
8.4.4 Rest of North America Enzymes Market by Application
Chapter 9. Company Profiles
9.1 BASF SE
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisition and Mergers:
9.1.5.3 Product Launches and Product Expansions:
9.1.5.4 Geographical Expansions:
9.2 International Flavors & Fragrances, Inc. (DuPont Nutrition)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.3 Associated British Foods PLC (Wittington Investments Limited)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.4 Koninklijke DSM N.V.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.4.5.2 Partnerships, Collaborations, and Agreements:
9.5 Novozymes A/S
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Acquisition and Mergers:
9.5.5.3 Product Launches and Product Expansions:
9.6 Kerry Group PLC
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Acquisition and Mergers:
9.7 Chr. Hansen Holding A/S
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Acquisition and Mergers:
9.8 Merck Group
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.9 Sanofi S.A.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.10. Codexis, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
9.10.5.2 Geographical Expansions:
Unique Offerings 